Lin-Chi Chen
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
-
- HIV/AIDS drug development and treatment 8
- Antifungal resistance and susceptibility 3
- Oncology 10
- Cancer-related Molecular Pathways 7
- Co-authors
- Arturo Casadevall (4 shared papers)Jean Mukherjee (1 shared paper)Júnia Soares Hamdan (1 shared paper)Robert Cherniak (1 shared paper)Sarah P. Franzot (1 shared paper)Steven Blotner (8 shared papers)Lee M. Krug (2 shared papers)Tamara L. Doering (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (3 papers)Blood (3 papers)Molecular Cancer Therapeutics (2 papers)Investigational New Drugs (2 papers)Infection and Immunity (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Lin-Chi Chen
18 papers receiving 614 citations
Peers
Comparison fields: 5 of 61
- Hematology 146
- Infectious Diseases 181
- Oncology 219
- Epidemiology 229
- Immunology 127
Countries citing papers authored by Lin-Chi Chen
This map shows the geographic impact of Lin-Chi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin-Chi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin-Chi Chen more than expected).
Fields of papers citing papers by Lin-Chi Chen
This network shows the impact of papers produced by Lin-Chi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin-Chi Chen. The network helps show where Lin-Chi Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin-Chi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 152 | |
| 2 | 1998 | 142 | |
| 3 | 2014 | 58 | |
| 4 | 1999 | 57 | |
| 5 | 2007 | 36 | |
| 6 | 2017 | 36 | |
| 7 | 2006 | 29 | |
| 8 | 2018 | 16 | |
| 9 | 2020 | 16 | |
| 10 | 2019 | 14 | |
| 11 | 1999 | 14 | |
| 12 | 2019 | 13 | |
| 13 | 2018 | 12 | |
| 14 | 2016 | 7 | |
| 15 | 2010 | 6 | |
| 16 | 1999 | 5 | |
| 17 | 2018 | 4 | |
| 18 | 2015 | 4 |
About Lin-Chi Chen
Lin-Chi Chen is a scholar working on Infectious Diseases, Oncology, Molecular Biology, Hematology and Epidemiology, having authored 18 papers that have together received 621 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Cancer-related Molecular Pathways (7 papers), Acute Myeloid Leukemia Research (5 papers), Antifungal resistance and susceptibility (3 papers), DNA Repair Mechanisms (3 papers), Fungal Infections and Studies (3 papers), Nail Diseases and Treatments (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Hematology (146 citations), Infectious Diseases (181 citations), Oncology (219 citations), Epidemiology (229 citations) and Immunology (127 citations). Lin-Chi Chen has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Arturo Casadevall, Jean Mukherjee, Júnia Soares Hamdan, Robert Cherniak, Sarah P. Franzot, Steven Blotner, Lee M. Krug, Tamara L. Doering, David L. Goldman and Liise‐anne Pirofski. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Blood, Molecular Cancer Therapeutics, Investigational New Drugs and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.